14th Annual EuroTIDES 2013

Topics

• Benchmark the latest Pre-Clinical and Clinical updates from 10+ leading companies
• The latest clinical findings and related challenges
• In vivo delivery and synthesising RNA and analogues at scale
• New and novel approaches to overcome the delivery challenge
• Strategy industry insights
• Oligos for Orphan Diseases
• Manufacturing capability, regulatory strategy and manufacturing control strategies
• Reduce cost and optimize your manufacturing strategy
• Therapeutic oligonucleotide drug development and GSK
• A novel second generation antisense oligonucleotide for treatment of the rare genetic disorder, Homozygous Familial Hypercholesterolemia

Who should Attend

Attendees from Pharma and Biotech companies.